| |
 |
|
Class Information
Number: 424/208.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Virus or component thereof > Retroviridae (e.g., feline leukemia virus, bovine leukemia virus, avian leukosis virus, equine infectious anemia virus, rous sarcoma virus, htlv-i, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the retrovirus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618642 |
Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins |
Nov. 17, 2009 |
| 7611712 |
Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide |
Nov. 3, 2009 |
| 7612168 |
Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
Nov. 3, 2009 |
| 7608271 |
Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group |
Oct. 27, 2009 |
| 7608273 |
Recombinant lentivirus encoding modified GP 120 signal sequences |
Oct. 27, 2009 |
| 7604804 |
Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120 |
Oct. 20, 2009 |
| 7595298 |
Polypeptides having anti-HIV activity and compositions comprising same |
Sep. 29, 2009 |
| 7592014 |
Stabilized viral envelope proteins and uses thereof |
Sep. 22, 2009 |
| 7588764 |
Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles |
Sep. 15, 2009 |
| 7585619 |
Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity |
Sep. 8, 2009 |
| 7582301 |
Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides |
Sep. 1, 2009 |
| 7579143 |
Method of assessing the effectiveness of a non-nucleoside reverse transcriptase inhibitor (NNRTI) on a human immunodeficiency virus type 1 (HIV-1)-infected patient |
Aug. 25, 2009 |
| 7579007 |
Production of "biological carriers" for induction of immune responses and inhibition of viral replication |
Aug. 25, 2009 |
| 7569228 |
Fusion proteins of non-attenuated HIV regulatory/accessory proteins |
Aug. 4, 2009 |
| 7556813 |
Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
Jul. 7, 2009 |
| 7556814 |
Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane |
Jul. 7, 2009 |
| 7553618 |
Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir |
Jun. 30, 2009 |
| 7553634 |
Extraction of integral membrane proteins |
Jun. 30, 2009 |
| 7550147 |
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
Jun. 23, 2009 |
| 7544467 |
Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV) |
Jun. 9, 2009 |
| 7541036 |
Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
Jun. 2, 2009 |
| 7537769 |
Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin |
May. 26, 2009 |
| 7534877 |
Non-M, non-O HIV-1 strains, fragments and uses |
May. 19, 2009 |
| 7534559 |
Feline polynucleotide vaccine formula |
May. 19, 2009 |
| 7534442 |
Immunogenic compositions comprising covalently bound polysaccharides, antigen, and bacterial toxoid |
May. 19, 2009 |
| 7531181 |
Gp120 specific antigens and uses thereof |
May. 12, 2009 |
| 7524927 |
Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions |
Apr. 28, 2009 |
| 7517532 |
Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
Apr. 14, 2009 |
| 7514233 |
Integrase cofactor |
Apr. 7, 2009 |
| 7507417 |
Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation |
Mar. 24, 2009 |
| 7501127 |
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara |
Mar. 10, 2009 |
| 7498178 |
Carrier of a diamond fine particle for immobilizing virus |
Mar. 3, 2009 |
| 7498130 |
Method of reducing viral load |
Mar. 3, 2009 |
| 7491400 |
Pharmaceutical compositions comprising attenuated HIV-1 nef-deficient viral particles |
Feb. 17, 2009 |
| 7491554 |
Carrier of a diamond fine particle for immobilizing virus |
Feb. 17, 2009 |
| 7488485 |
DNA vaccine compositions and methods of use |
Feb. 10, 2009 |
| 7488484 |
Nucleic acid expression cassette encoding an HIV polyprotein comprising the ancillary gene products Vif, Vpu, and Nef |
Feb. 10, 2009 |
| 7485416 |
Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity |
Feb. 3, 2009 |
| 7482016 |
Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides |
Jan. 27, 2009 |
| 7479553 |
Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins |
Jan. 20, 2009 |
| 7476386 |
Mixed lipopeptide micelles for inducing an immune response |
Jan. 13, 2009 |
| 7470430 |
Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
Dec. 30, 2008 |
| 7459270 |
Modified Vaccinia Ankara virus variant |
Dec. 2, 2008 |
| 7442525 |
Method for expressing HIV polypeptides |
Oct. 28, 2008 |
| 7439052 |
Method of making modified immunodeficiency virus particles |
Oct. 21, 2008 |
| 7429653 |
Stabilized soluble glycoprotein trimers |
Sep. 30, 2008 |
| 7427468 |
Anti-TSG101 antibodies and their uses for treatment of viral infections |
Sep. 23, 2008 |
| 7407662 |
Modified viral particles with immunogenic properties and reduced lipid content |
Aug. 5, 2008 |
| 7407663 |
Modified immunodeficiency virus particles |
Aug. 5, 2008 |
| 7399473 |
Virus coat protein/receptor chimeras and method of use |
Jul. 15, 2008 |
|
|
|
